The purpose of this study is to evaluate TBE antibody persistence from 7 to 10 years after
the first booster TBE vaccination with FSME-IMMUN 0.5ml.
Biological: FSME-IMMUN 0.5 ml
We will connect you to the doctor responsible for this trial and help you get more information.
Locations near you
Unfortunately, there are no recruiting locations near you. Please check the list with all locations below.
Full eligibility criteria for NCT01582698
Ages eligible for Study
25 Years and older
Genders eligible for Study
Accepts Healthy Volunteers
Subjects who participated in the first and second precursor studies will be eligible for
participation in this study if:
- they understand the nature of the study, agree to its provisions and provide written
- they received the first booster vaccination with FSME-IMMUN 0.5ml during the first
precursor study and did not receive a second booster vaccination in the second
- blood was drawn after their first booster vaccination in the first precursor study
Subjects will be excluded from participation in this study if they:
- received any TBE vaccination since their first booster vaccination with FSME-IMMUN
- have a history of infection with or vaccination against other flaviviruses (e.g.
dengue fever, yellow fever, Japanese B-encephalitis) since their first booster
vaccination with FSME-IMMUN 0.5ml
- are known to be HIV positive since their first booster vaccination with FSME-IMMUN
- have a known or suspected problem with drug or alcohol abuse
All locations for NCT01582698
Prywatny Gabinet Lekarski
Dębica, Poland, 39-200
"John Paul II" Cracow Specialist Hospital, Department of Pediatric Neuroinfections and Neurology
Krakow, Poland, 31-202
View full eligibility
Tris trial is registered with FDA with number: NCT01582698. The sponsor of the trial is Pfizer and it is looking for 243 volunteers for the current phase.
Official trial title: Open-label Phase 4 Study to Investigate the Seropersistence of Tick-borne Encephalitis (TBE) Virus Antibodies From 7 to 10 Years After the First Booster and the Response to a Second Booster Vaccination With FSME-IMMUN 0.5ml in Adults
1What's a trial
4Get in touch
What's a trial
Not sure you're well informed about clinical trials? Learn more about their benefits, risks and other important details.
Enter your details like condition, age, gender and other preferences and we will show you a list of all relevant clinical trials.
Review the summary of the selected clinical trial and all the locations near you in order to see if it's of interest to you.
Get in touch
You've found an interesting trial? We'll need a bit more information about you so we can connect you to the doctor in charge.
Some people want to consult their doctor before considering participation in a clinical trial. This is absolutely normal as your doctor should know your medical history and should be able to advise you. If you want you can easily share the information for this trial with your doctor by clicking on the button below.